Drug abuse in schizophrenic patients: clinical correlates and reasons for use.
about
Substance abuse and schizophrenia: pharmacotherapeutic interventionCannabis and psychosis/schizophrenia: human studiesGene-environment interplay between cannabis and psychosisSubstance dependence: Decades apart in a teaching hospitalRevisiting the 'self-medication' hypothesis in light of the new data linking low striatal dopamine to comorbid addictive behaviorA neurobiological basis for substance abuse comorbidity in schizophreniaPrevalence and correlates of sexual activity and HIV-related risk behavior among psychiatric outpatientsThe role of cannabinoid 1 receptor expressing interneurons in behavior.Do patients think cannabis causes schizophrenia? - A qualitative study on the causal beliefs of cannabis using patients with schizophreniaCannabis abuse and brain morphology in schizophrenia: a review of the available evidence.European network for promoting the physical health of residents in psychiatric and social care facilities (HELPS): background, aims and methodsDo treatment improvements in PTSD severity affect substance use outcomes? A secondary analysis from a randomized clinical trial in NIDA's Clinical Trials Network.Reasons for cannabis use among youths at ultra high risk for psychosis.Vulnerability Factors for the Psychiatric and Behavioral Effects of Cannabis.Substance abuse and cognitive functioning in schizophrenia.Are cannabis use disorders associated with an earlier age at onset of psychosis? A study in first episode schizophrenia.Multimorbidity patterns in primary care: interactions among chronic diseases using factor analysis.Pharmacologically-mediated reactivation and reconsolidation blockade of the psychostimulant-abuse circuit: a novel treatment strategy.Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial.Perceived reasons for and consequences of substance abuse among patients with psychosisPhysical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care.DOUBLE TROUBLE IN RECOVERY: SELF-HELP FOR PEOPLE WITH DUAL DIAGNOSES.Comorbid substance abuse and brain morphology in recent-onset psychosisSubstance use and cognition in early psychosisGender differences in subjective experience and treatment of bipolar disorderComorbid substance use disorders in schizophrenia: a latent class approach.Treatment of the special patient with schizophrenia.Genetic predisposition to schizophrenia associated with increased use of cannabis.A randomized trial of clozapine vs. other antipsychotics for cannabis use disorder in patients with schizophrenia.Perceived reasons for substance misuse among persons with a psychiatric disorder.The Potential Role of Long-acting Injectable Antipsychotics in People with Schizophrenia and Comorbid Substance Use.Alcohol and cannabis use and mortality in people with schizophrenia and related psychotic disorders.Substance use disorder and schizophrenia: prevalence and sociodemographic characteristics in the Latin American population.Substance use and HIV risk in a sample of severely mentally Ill Puerto Rican women.Cognitive Enhancement Therapy Improves Frontolimbic Regulation of Emotion in Alcohol and/or Cannabis Misusing Schizophrenia: A Preliminary StudyA perfect platform: combining contingency management with medications for drug abuseSubstance dependence and remission in schizophrenia: A comparison of schizophrenia and affective disordersCorrelates of substance use disorder among psychiatric outpatients: focus on cognition, social role functioning, and psychiatric statusShorter interpuff interval is associated with higher nicotine intake in smokers with schizophreniaCharacterizing the longitudinal patterns of substance use among individuals diagnosed with serious mental illness after psychiatric hospitalization.
P2860
Q24621711-C4F8A102-FEC1-419B-A1A0-5F0DAB1EAA3AQ24628837-B0761E2B-EE16-4530-955D-FB2BF28B9947Q24643510-707E957D-CE70-4047-99ED-32F3A1CD6519Q24658425-2D654836-C258-457F-8E5B-B6E95E060F9CQ26801102-CAF8B58A-7B52-4D12-95D1-A8144B8099C4Q28347063-70F69051-EAB4-4DEA-95A5-B9AEA9139503Q28362651-6FED173E-6C4F-480E-B69E-C665B8813635Q30417825-1AE9D1FC-E524-498A-ACF5-5848ADD6FF5CQ30479116-CAECDE74-E20E-491F-B86D-444525AF19E1Q30558464-B575D533-6F01-41FF-9A72-181D49A393CCQ33498111-2BAF2B0F-C35F-4277-AFF4-8D8B7BE101A7Q33590538-7E0381A1-1202-4DF6-BCAC-97EBE64E60FBQ33662861-37C74A70-535C-41FC-83B2-5691C5D6D38CQ33664684-048A120C-EAC1-4DC1-852A-956C68E50A0EQ33921874-2570ACE9-4475-43AE-9DD4-35C98942397CQ33976751-D6378B57-3227-4240-9EB3-5A994479B534Q34185797-25EA2CCF-9B39-4D19-A3D7-89474FD06FBAQ34256300-4AE0281E-5EC5-4B15-83AC-48E8224282B8Q34347478-87BC1FD9-B278-40F9-9CEF-AD201396DF03Q34516286-721D22E7-5CA0-44C5-9A76-DC136FEA0CFEQ34623350-65EF655F-6BDF-4CC5-9CD3-C20269DB105FQ34665369-2CDC1A75-7D51-4E9F-A7E8-42876EAA97CEQ34901749-4E2FA746-EFC9-4120-84F5-C9CE14F234B8Q35101398-2DFC513A-BA72-4DFC-AB8E-25F48B41E662Q35142375-5E6E2C31-BA74-4F33-9B8D-19B721B4552AQ35229933-6AF7291E-3131-4380-B496-863D272410D9Q35236370-2735F716-F12D-499F-B006-B026479886A2Q35246819-88A26325-22CE-4A1E-9DF5-0DC31EA77316Q35529636-6F027D0B-4ACF-4654-BEAA-7942C0D785B7Q35677193-CFC92BB1-0698-4B4E-AD8D-2249843DC503Q36059843-D04E86EA-AB16-4F62-AF7B-ED0B2741DC91Q36083997-41E0BB28-75D2-4886-AF1D-358B1B7C5873Q36092716-863E3F85-7AB6-4A37-88AA-5E65D2A95862Q36355915-E5BEBF0E-C2CB-498C-9CD9-782A8794E1ADQ36452922-CE5110B9-845A-4093-80BB-212FF0E25C83Q36631554-45899826-EF46-4F83-814A-1559895E3176Q36712877-81A075D3-2F15-44E7-BCE6-689CEE9EA74AQ36727032-911FC253-328C-40DD-8702-C17B4771FB23Q36848924-52208D8C-E615-4C40-91DE-5672EE15C376Q36920503-86A4233A-FDD3-4E04-AF94-95CE2C4881C6
P2860
Drug abuse in schizophrenic patients: clinical correlates and reasons for use.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh
1991年學術文章
@zh-hant
name
Drug abuse in schizophrenic patients: clinical correlates and reasons for use.
@en
Drug abuse in schizophrenic patients: clinical correlates and reasons for use.
@nl
type
label
Drug abuse in schizophrenic patients: clinical correlates and reasons for use.
@en
Drug abuse in schizophrenic patients: clinical correlates and reasons for use.
@nl
prefLabel
Drug abuse in schizophrenic patients: clinical correlates and reasons for use.
@en
Drug abuse in schizophrenic patients: clinical correlates and reasons for use.
@nl
P2093
P356
P1476
Drug abuse in schizophrenic patients: clinical correlates and reasons for use.
@en
P2093
P304
P356
10.1176/AJP.148.2.224
P407
P577
1991-02-01T00:00:00Z